As you know, I’m a research junkie and not much of a conspiracy theorist when it comes to COVID-19 or anything else.
But I have to wonder why, faced with a worldwide pandemic, that governments and the media are all ignoring solid scientific evidence from doctors of treatments demonstrated to lower the incessant mortality rate of COVID-19.
I bet you’ve never heard of the Front Line COVID-19 Critical Care Alliance.
When the pandemic struck, a number of doctors from major academic medical centers, with some 200 years’ worth of combined experience in critical care medicine, plus about 1000 published papers in scientific journals under their belts, called an emergency meeting after noticing that the vast majority of critically ill COVID patients given the standard treatment recommended by national and international health care organizations were dying.
The greatest mystery of all, to their minds, was why so many patients were dying of acute respiratory failure.
They decided to form a working group to find a treatment protocol for COVID-19, particularly for patients going into intensive care units.
The group specifically sought out Dr Paul Marik, professor of medicine and chief of the division of pulmonary and critical care medicine at Eastern Virginia Medical School in Norfork, Virginia.
Marik is expert in treating ICU patients with severe infections like bacterial sepsis, and it was he who first developed what he called a ‘HAT’ treatment – a mix of Hydrocortisone (a steroid), intravenous Ascorbic acid (high dose vitamin C), and intravenous Thiamine (vitamin B1) for such patients. Published studies have since shown that this treatment can achieve high survival rates.
Dubbing themselves the Front Line COVID-19 Critical Care Alliance, Marik and his colleagues met extensively, studied all the clinical and pathological data about COVID, and began discussions with a number of frontline intensive care unit experts working in some of the early outbreak areas, like China, Italy and New York.
To Marik and these other concerned doctors, COVID seemed to be behaving a bit like sepsis. They figured they could get better results with the sickest patients by tweaking Marik’s initial protocol.
After comparing notes of what was working with what wasn’t, they formulated the MATH+ treatment protocol, specifically for hospitalized patients, and launched it in March 2020.
The MATH part of MATH+ stands for intravenous Methylpredisolone (another steroid), high dose intravenous Ascorbic acid, high dose Thiamine and Heparin (to prevent blood clotting).
The ‘plus’ stands for optional further interventions: melatonin, zinc, vitamin D3, a statin, famotidine (an H2 blocker used to treat indigestion or stomach ulcers) and intravenous magnesium.
Here’s the full protocol: https://COVID19criticalcare.com/math-hospital-treatment/pdf-translations/
In their research, the FLCCC Alliance discovered that when given intravenously in these emergency situations, steroids like prednisolone and vitamin C work together synergistically to improve survival in patients with acute respiratory distress syndrome.
Thiamine helps the body optimize its ability to use oxygen and can protect the heart and immune system, and heparin is a well established anti-coagulant – useful in this instance because critically ill COVID patients show excessive levels of blood clotting.
The other ‘plus’ interventions all have been shown to help with specific symptoms.
Although the Alliance created a website and published the MATH+ protocol in many languages back in March, as of this writing only two centers have systematically employed it to treat hospitalized COVID patients: the United Memorial Hospital in Houston, Texas and Norfolk General Hospital in Norfolk, Virginia.
Nevertheless the Alliance has been keeping careful track of those hospital patients under this regime, and on August 5, revealed a case study of the results: of more than 300 patients treated early on with the MATH+ protocol, average hospital mortality was about 5 percent, compared with an average mortality of nearly 23 percent of patients in hospitals in the US, Italy and China who were given the standard protocols
So this begs an obvious question. Here you have a team of eminent specialists, who devised a system to treat serious cases of COVID that reduces mortality by at least five times - from nearly one in four patients to one in 20.
Why is this not being adopted by every hospital and every government around the world? By the Centers for Disease Control, by NICE in the UK, by the World Health Organization?
If you want to figure out why, just pull out your calculator. The UK has just signed a deal for six experimental vaccines with Belgian pharmaceutical company Janssen and the US biotech company Novavax, for a total stockpile to 340 million doses – enough to vaccinate every British man, woman and child five times.
In America, the US government has spent about $10 billion over a deal with Moderna, Inc. to manufacture and deliver 100 million doses of the company’s COVID-19 vaccine candidate.
With this deal, the US government has turned into a pharmaceutical company, owning (and presumably profiting from) these vaccine doses.
It’s also made a separate deal with drug giant Pfizer for a total of nearly $2 billion in investment – ensuring that Pfizer will have a market for its drug, even before it has been created.
Overrall, after splitting its revenue with its partner BioNTech, Pfizer is due to make an estimated $13 billion by the end of next year – about the same as its all-time bestselling drug Lipitor during its most popular year.
Big Pharma, in turn, has been showering the US Congress with some $11 million in campaign contributions thus far this year. The PAC for Pfizer sent some 548 checks to lawmakers – more than any other drug company.
Now compare the gigantic money at stake here with the kinds of profits these drug companies will make with what’s used in the Alliance’s protocol: a few out-of-patent drugs and some intravenous vitamins.
You want to know why you haven’t heard about the Marik and his alliance?
It’s simple. Just do the math.